Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS
Clinical trial NCT04987671 · UNKNOWN
Trial details
- NCT number
- NCT04987671
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-05
- Primary completion
- 2022-05-11
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.